+

TNSN97114A1 - Granule pour la preparation des compositions a desintegration et dissolution rapides comprenant une teneur elevee d'un principe actif - Google Patents

Granule pour la preparation des compositions a desintegration et dissolution rapides comprenant une teneur elevee d'un principe actif

Info

Publication number
TNSN97114A1
TNSN97114A1 TNTNSN97114A TNSN97114A TNSN97114A1 TN SN97114 A1 TNSN97114 A1 TN SN97114A1 TN TNSN97114 A TNTNSN97114 A TN TNSN97114A TN SN97114 A TNSN97114 A TN SN97114A TN SN97114 A1 TNSN97114 A1 TN SN97114A1
Authority
TN
Tunisia
Prior art keywords
preparation
active ingredient
granule
high content
rapid disintegration
Prior art date
Application number
TNTNSN97114A
Other languages
English (en)
Inventor
Bernardus Loenardus Johannes-Co Yamanouc Dijkgraaf
Aart-Co Yamanouchi Europe B V Muhlenbruch
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8224133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN97114(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Publication of TNSN97114A1 publication Critical patent/TNSN97114A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

GRANULE CONTENANT UN INGREDIENT ACTIF, AYANT UNE SOLUBILITE DANS L'EAU DE 1:>10, EN LEMANGE AVEC <15% EN POIDS D'UNE CELLULOSE DISPERSIBLE DANS L'EAU, FOURNIT POUR LA PREPARATION DE COMPOSITIONS A DESINTEGRATION RAPIDE ET A DISSOLUTION RAPIDE
TNTNSN97114A 1996-07-03 1997-07-01 Granule pour la preparation des compositions a desintegration et dissolution rapides comprenant une teneur elevee d'un principe actif TNSN97114A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201829 1996-07-03
US08/770,421 US5837292A (en) 1996-07-03 1996-12-20 Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Publications (1)

Publication Number Publication Date
TNSN97114A1 true TNSN97114A1 (fr) 2005-03-15

Family

ID=8224133

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN97114A TNSN97114A1 (fr) 1996-07-03 1997-07-01 Granule pour la preparation des compositions a desintegration et dissolution rapides comprenant une teneur elevee d'un principe actif

Country Status (35)

Country Link
US (1) US5837292A (fr)
EP (1) EP0910344B1 (fr)
JP (1) JP4159607B2 (fr)
CN (1) CN1131025C (fr)
AR (1) AR008252A1 (fr)
AT (1) ATE237314T1 (fr)
AU (1) AU731276B2 (fr)
BG (1) BG64114B1 (fr)
BR (1) BR9710181B1 (fr)
CA (1) CA2258841C (fr)
CO (1) CO4890859A1 (fr)
CZ (1) CZ295893B6 (fr)
DE (1) DE69720995T2 (fr)
DK (1) DK0910344T3 (fr)
EA (1) EA001537B1 (fr)
EG (1) EG23814A (fr)
ES (1) ES2197351T3 (fr)
HU (1) HU225115B1 (fr)
ID (1) ID17128A (fr)
IL (1) IL127364A (fr)
JO (1) JO1969B1 (fr)
MY (1) MY116124A (fr)
NO (1) NO320767B1 (fr)
NZ (1) NZ333247A (fr)
PE (1) PE89798A1 (fr)
PL (1) PL188235B1 (fr)
PT (1) PT910344E (fr)
SI (1) SI0910344T1 (fr)
SK (1) SK284175B6 (fr)
TN (1) TNSN97114A1 (fr)
TR (1) TR199802762T2 (fr)
TW (1) TW473392B (fr)
UA (1) UA61917C2 (fr)
WO (1) WO1998001114A1 (fr)
ZA (1) ZA975848B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129932A (en) * 1997-09-05 2000-10-10 Merck & Co., Inc. Compositions for inhibiting platelet aggregation
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
US6177101B1 (en) 1998-06-11 2001-01-23 Pharmacia & Upjohn Company Delavirdine high strength tablet formulation
US20090060995A1 (en) * 2005-01-13 2009-03-05 Kamalinder Kaur Singh Dispersible sustained release pharmaceutical compositions
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
WO2000069417A1 (fr) * 1999-05-14 2000-11-23 Eli Lilly And Company Elaboration d'un produit pharmaceutique en vrac uniformement dissout
HU227070B1 (en) * 1999-08-11 2010-06-28 Egis Gyogyszergyar Nyilvanosan Immediate release pharmaceutical composition containing ciprofloxacin and process for its production
UY26615A1 (es) * 2000-03-16 2001-10-25 Pfizer Prod Inc Inhibidor de la glucogeno fosforilasa.
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
JP2004522752A (ja) * 2001-02-05 2004-07-29 アール．ピー． シェーラー テクノロジーズ インコーポレイテッド 薬学的活性剤の味を軽減するための方法および組成物
EP1285649A1 (fr) * 2001-08-23 2003-02-26 Cimex AG Comprimé dispersible à deux couches comprenant de l'amoxicilline et du clavulanate dans des couches séparées
CN1688291A (zh) * 2002-02-01 2005-10-26 辉瑞产品公司 含有固体药物分散体的即刻释放剂型
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
BR0312728A (pt) * 2002-07-16 2005-04-26 Ranbaxy Lab Ltd Formulação em tablete dispersìvel e processo para sua preparação
AU2003247023A1 (en) * 2002-08-02 2004-02-25 Ranbaxy Laboratories Limited A process for the preparation of dispersible tablet of cephalexin
JP4702763B2 (ja) * 2003-07-30 2011-06-15 塩野義製薬株式会社 結晶セルロースを含有する安定な錠剤
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
HUE045411T2 (hu) * 2003-09-12 2019-12-30 Amgen Inc Cinakalcet HCl gyors feloldódású készítmény
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
WO2008008120A1 (fr) * 2006-07-14 2008-01-17 Fmc Corporation Forme solide
JP5201819B2 (ja) * 2006-11-22 2013-06-05 エスエス製薬株式会社 固形組成物
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
US20120040001A1 (en) * 2009-02-12 2012-02-16 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and rapidly disintegrating compression-molded material used the same
EP2575777A1 (fr) * 2010-06-03 2013-04-10 Mahmut Bilgic Formulation comprenant du cefpodoxime proxétil et de l'acide clavulanique
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
WO2013151517A1 (fr) * 2012-04-04 2013-10-10 Mahmut Bilgic Formulations en comprimés comprenant du cefpodoxime proxétil et de l'acide clavulanique
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
EP3135300B1 (fr) * 2014-04-21 2022-03-30 Daicel Corporation Composition particulaire apte à se désagréger comprenant de la cellulose microfibreuse
CN110051639B (zh) * 2019-03-15 2021-08-31 河北嘉迈医药科技有限公司 一种快速崩解型尼麦角林片及其制备方法
CN117683469B (zh) * 2023-10-24 2024-08-27 绍兴拓邦新能源股份有限公司 一种晶硅片背面碱抛光固态添加剂及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
NL184308C (nl) * 1975-07-24 1989-06-16 Takeda Chemical Industries Ltd Werkwijze voor het bereiden van l-ascorbienzuurgranules.
JPS58403B2 (ja) * 1975-07-24 1983-01-06 武田薬品工業株式会社 Ｌ− アスコルビンサンセイザイノ セイゾウホウ
GB1560475A (en) * 1975-10-11 1980-02-06 Lilly Industries Ltd Pharmaceutical formulation
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
EP0200252B1 (fr) * 1985-05-02 1999-03-10 Yamanouchi Europe B.V. Comprimés contenant de la triméthoprime et un sulfonamide
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
EP0281200B1 (fr) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Composition pharmaceutique, granulé pharmaceutique et leur procédé de fabrication
EP0330284B1 (fr) * 1988-02-25 1994-07-27 Yamanouchi Europe B.V. Procédé de préparation d'un granulé pharmaceutique
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
IL109097A0 (en) * 1993-04-03 1994-06-24 Knoll Ag Delayed release micro tablet of beta-phenylpropiophenone derivatives and its production

Also Published As

Publication number Publication date
ATE237314T1 (de) 2003-05-15
JP2000513727A (ja) 2000-10-17
CA2258841C (fr) 2006-05-30
TW473392B (en) 2002-01-21
BR9710181B1 (pt) 2009-08-11
HUP9903308A3 (en) 2001-03-28
MY116124A (en) 2003-11-28
ID17128A (id) 1997-12-04
HU225115B1 (hu) 2006-06-28
SK284175B6 (sk) 2004-10-05
CN1224348A (zh) 1999-07-28
BG103047A (en) 1999-07-30
IL127364A (en) 2003-04-10
CZ699A3 (cs) 1999-04-14
PL330958A1 (en) 1999-06-21
NZ333247A (en) 2000-07-28
PT910344E (pt) 2003-09-30
EA001537B1 (ru) 2001-04-23
DE69720995T2 (de) 2003-11-13
EG23814A (en) 2007-09-12
AR008252A1 (es) 1999-12-29
NO986157D0 (no) 1998-12-28
BR9710181A (pt) 1999-08-10
US5837292A (en) 1998-11-17
CO4890859A1 (es) 2000-02-28
HUP9903308A2 (hu) 2000-03-28
EP0910344B1 (fr) 2003-04-16
ES2197351T3 (es) 2004-01-01
SK176798A3 (en) 2000-04-10
DK0910344T3 (da) 2003-07-07
AU731276B2 (en) 2001-03-29
ZA975848B (en) 1999-04-12
EP0910344A1 (fr) 1999-04-28
CN1131025C (zh) 2003-12-17
BG64114B1 (bg) 2004-01-30
JO1969B1 (en) 1997-12-15
NO320767B1 (no) 2006-01-23
DE69720995D1 (de) 2003-05-22
EA199900075A1 (ru) 1999-06-24
TR199802762T2 (xx) 1999-03-22
HK1021511A1 (en) 2000-06-16
SI0910344T1 (en) 2003-08-31
PE89798A1 (es) 1999-01-12
CZ295893B6 (cs) 2005-11-16
UA61917C2 (uk) 2003-12-15
PL188235B1 (pl) 2004-12-31
AU3342197A (en) 1998-02-02
IL127364A0 (en) 1999-10-28
NO986157L (no) 1999-02-01
JP4159607B2 (ja) 2008-10-01
CA2258841A1 (fr) 1998-01-15
WO1998001114A1 (fr) 1998-01-15

Similar Documents

Publication Publication Date Title
TNSN97114A1 (fr) Granule pour la preparation des compositions a desintegration et dissolution rapides comprenant une teneur elevee d&#39;un principe actif
EP0693281A3 (fr) Formulations pharmaceutiques contenant de la fluoxétine
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
NZ510991A (en) Use of formulations for hydrophobic pharmaceutical agents in treatment or prevention of cell proliferative disorders
IT1246350B (it) Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili
KR920003971A (ko) 점안액 조성물
DE68901014D1 (de) Entzuendungshemmendes ibuprofen enthaltendes arzneimittel, das in waessriger loesung keinen bitteren geschmack, keine reizung des kehlkopfes und keine intestinale toxizitaet aufweist.
TNSN99024A1 (fr) Procede de preparation d&#39;une composition pharmaceutique destinee au traitement de l&#39;insuffisance cardiaque
EA200200251A1 (ru) Эктопаразитицидные водные суспензионные препараты спинозинов
PT1091740E (pt) Preparacoes aquosas semi-solidas para administracao oral de toltrazuril-sulfona
TNSN97186A1 (fr) Nouvelles compositions solides a base de derive cellulosique insoluble et de derives de 1 - aryl - pyrazole.
RU2001120110A (ru) Фармацевтическая смесь, содержащая профен
JPH0334919A (ja) 浴用剤
NZ509593A (en) Compressed compositions comprising clarified xanthan gum
AU3772697A (en) Pharmaceutical composition to be administered orally
SU1189876A1 (ru) Дезинфицирующее средство &#34;дезнор
FR2597338A1 (fr) Bain moussant effervescent.
BRPI0403668A (pt) composições farmacêuticas de desintegração oral com altas concentrações de aspartame
FR2821552B1 (fr) Procede pour rendre hydrosoluble un principe actif naturellement peu ou pas soluble dans l&#39;eau et ses utilisations
BG104676U (en) Means for varoatose control
RU2001102026A (ru) Препарат интерферона
TH13559A (th) องค์ประกอบทางเภสัชที่ใช้ในการรักษาโรคต้อหิน
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载